NHS patients could receive a daily pill which can HALF the frequency of their crippling migraine headaches
The new treatment is a type of medication called a CGRP inhibitor, which blocks the effect of calcitonin gene-related peptide - a protein known to trigger debilitating migraines.
Source: dailymail.co.uk